TGFB1 and chronic kidney disease: In addition, this agent has been shown to attenuate the TGFβ induced fibrosis in renal tubular epithelial cells via upregulation of PTEN and TIMP3, and suppression of miR21, which highlights the anti-fibrotic feature of quercetin for CKD patients [132].